Back to ALXN Stock Lookup

ALXN Related Analyst Ratings

Apr 25, 2013 02:07 PM Alexion Pharmaceuticals (ALXN) Fundamentals Strong - Analyst

Apr 22, 2013 02:59 PM Management Comments on Thursday Could Boost Shares of Alexion (ALXN)

Mar 28, 2013 10:35 AM Analysts Sound Horn on Alexion (ALXN)… Buy Weakness

Feb 20, 2013 07:34 AM Lazard Capital Upgrades Alexion Pharmaceuticals (ALXN) to Buy

Feb 15, 2013 02:43 PM Baird Bullish on Alexion (ALXN), Says Beat & Raise Will Be Pattern

Jan 2, 2013 05:53 PM Janney Montgomery Scott Starts Alexion Pharmaceuticals (ALXN) at Neutral

Dec 13, 2012 09:07 AM Goldman Sachs Resumes Alexion Pharmaceuticals (ALXN) at Buy, Says Opportunity Underestimated

Dec 7, 2012 06:56 AM Citi Starts Alexion Pharmaceuticals (ALXN) at Neutral

Nov 9, 2012 09:48 AM Guggenheim Starts Alexion Pharmaceuticals (ALXN) at Buy

Oct 25, 2012 01:36 PM Analysts Raise Questions about Risk/Reward at Alexion Pharmaceuticals (ALXN)

Sep 24, 2012 09:01 AM Canaccord Genuity Boosts Target on Alexion Pharmaceuticals (ALXN) After Pipeline Analysis

Sep 14, 2012 01:11 PM Barclays Lifts Target on Alexion Pharmaceuticals (ALNX) After Adding NMO Into Model

Aug 24, 2012 07:04 AM ThinkEquity Starts Alexion Pharmaceuticals (ALXN) at Hold

Aug 7, 2012 07:50 AM Lazard Capital Starts Alexion Pharmaceuticals (ALXN) at Neutral

Jul 26, 2012 05:35 PM Barclays Keeps 'Overweight' on Alexion Pharmaceuticals (ALXN); Beat & Raise with Three Potential Catalysts Ahead

Jul 26, 2012 01:47 PM Canaccord Genuity Raises Estimates on Alexion Pharmaceuticals (ALXN); Pleased with aHUS Launch Progress

Jul 13, 2012 07:09 AM Baird Reiterates an 'Outperform' on Alexion Pharmaceuticals (ALXN); Raising N-T Estimates Ahead of Qtr

Apr 25, 2012 02:13 PM Oppenheimer updates 2012-2015 EPS Estimates on Alexion Pharmaceuticals (ALXN)

Apr 25, 2012 01:52 PM Barclays Maintains an 'Overweight' on Alexion Pharmaceuticals (ALXN); Raising PT to $104

Apr 25, 2012 09:48 AM Canaccord Genuity Maintains a 'Buy' on Alexion Pharmaceuticals (ALXN); Raising PT and Estimates on Beat & Raise

Apr 25, 2012 09:03 AM Alexion Pharmaceuticals (ALXN) High Valuation: Jefferies Says Hold, Ups Price Target

Apr 20, 2012 10:05 AM Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect

Mar 29, 2012 06:03 PM Baird Reiterates an 'Outperform' on Alexion Pharmaceuticals (ALXN); Enobia Investment Starts Bearing Fruit

Mar 29, 2012 03:33 PM Oppenheimer Raises Target on Alexion (ALXN) to $100 as Asfotase Alfa Data Looks Promising

Mar 26, 2012 08:57 AM Canaccord Genuity Starts Alexion Pharmaceuticals (ALXN) at Buy

Mar 22, 2012 08:28 AM Goldman Sachs Said New Soliris Case Study a Positive for Alexion Pharmaceuticals (ALXN), Raises Price Target

Mar 2, 2012 07:29 AM Goldman Sachs Reiterates Top Rating on Alexion Pharmaceuticals (ALXN) After Meetings

Feb 23, 2012 11:55 AM UPDATE - UBS Upgraded Alexion Pharmaceuticals (ALXN) to Buy; Sustained Growth of Soliris in Multiple Segments

Feb 23, 2012 08:03 AM UBS Upgrades Alexion Pharmaceuticals (ALXN) to Buy

Feb 10, 2012 03:12 PM Leerink Swann Raises Price Target on Alexion (ALXN), Sees Upside in Guidance

Feb 10, 2012 02:51 PM Deutsche Raises Price Target on Alexion Pharm (ALXN), Encouraged About R&D Ramp Up

Feb 10, 2012 01:26 PM Jefferies Maintains a 'Hold' on Alexion Pharmaceuticals (ALXN); Q4 Soliris Sales Beat; FY12 Sales Guidance Slightly Higher

Feb 10, 2012 07:50 AM Baird Upgrades Alexion Pharmaceuticals (ALXN) to Outperform; Getting Off The Sidelines

Feb 3, 2012 07:50 AM Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List

Jan 24, 2012 10:21 AM Oppenheimer Boots Price Target On Alexion (ALXN) Following Asfotase Alfa Review

Jan 23, 2012 02:43 PM Goldman Sachs Lifts Price Target On Alexion Pharmaceuticals (ALXN) to $83

Jan 4, 2012 11:12 AM Goldman Sachs Highlights Best and Worst in Biotech for 2012

Dec 29, 2011 08:08 AM Leerink Swann Maintains an 'Outperform' on Alexion Pharmaceuticals (ALXN); Not a Cheap Acquisition, But Quality of the Asset May Win the Day

Dec 15, 2011 11:41 AM Biotech M&A Will Be In Focus in 2012 - Goldman

Oct 21, 2011 12:56 PM UBS Maintains a 'Neutral' on Alexion Pharmaceuticals (ALXN); Raising Estimates on aHUS, Margins

Oct 21, 2011 09:58 AM Jefferies Maintains a 'Hold' on Alexion Pharmaceuticals (ALXN); Solid 3Q11; Focus on Soliris Sales Expansion from aHUS

Oct 4, 2011 08:08 AM JPMorgan Starts Alexion Pharmaceuticals (ALXN) at Overweight

Sep 27, 2011 09:08 AM Baird Reiterates a 'Neutral' on Alexion Pharmaceuticals (ALXN); Raising Estimates and Target Again

Sep 27, 2011 07:05 AM Deutsche Bank Maintains a 'Buy' on Alexion Pharmaceuticals (ALXN); aHUS in the Books - Dry AMD & NMO Next - Value Left

Sep 26, 2011 03:53 PM Goldman Sachs Lifts Price Target On Alexion Pharmaceuticals (ALXN)

Sep 23, 2011 02:59 PM Baird Reiterates a 'Neutral' on Alexion Pharmaceuticals (ALXN); Regulatory Two-Fer; aHUS Indication Cleared in US/EU

Sep 21, 2011 01:27 PM JPMorgan Highlights Possible S&P 500 Additions

Jul 22, 2011 10:20 AM UBS Maintains a 'Neutral' on Alexion Pharmaceuticals (ALXN); Missed a Step-Up; Neutral on Catalysts

Jul 22, 2011 08:42 AM Goldman Sachs Lifts Estimates and Price Target on Alexion Pharmaceuticals (ALXN)

Jul 22, 2011 08:37 AM Needham & Company Maintains a 'Hold' on Alexion Pharmaceuticals (ALXN); Hot Quarter and Fiery Fundamentals Along with Sizzling Valuation

Back to ALXN Stock Lookup